Jianqiang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianqiang Wang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Yong Hai
Department of Orthopaedic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
5 shared publications - Haoshuang Geng
Department of Orthopaedic Surgery, Beijing Chaoyang Hospital, Capital Medical University of China, Beijing, China
3 shared publications - Lijin Zhou
Department of Orthopaedic Surgery, Beijing Chaoyang Hospital, Capital Medical University of China, Beijing, China
2 shared publications - Bo Han
Joint Laboratory for Research & Treatment of Spinal Cord Injury in Spinal Deformity, Capital Medical University, 100069 Beijing, China
1 shared publication - Changqing Zhang
Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Duan Sun
Department of Orthopedic Surgery, Beijing Chaoyang Hospital, Capital Medical University, 100020 Beijing, China
1 shared publication
Latest Publications
- Open Access
- 6 November 2026
- Published by Wiley in Orthopaedic Surgery
The Influence of Height‐Adjusted Nutritional Status Assessment on Complications Following Growing‐Rod Surgery for Early‐Onset Scoliosis
Objectives: Accurate nutritional assessment in children with early‐onset scoliosis (EOS) is challenging because spinal deformity reduces measured standing height and may distort BMI‐for‐age classification. This study aimed to evaluate, using a longitudinal design, height‐adjusted nutritional status before each growing‐rod procedure throughout the treatment course and to investigate its association with postoperative complications in patients with EOS. Methods: A retrospective cohort study included 53 patients with EOS who underwent 86 growing‐rod procedures between January 2016 and January 2023, with each procedure serving as the unit of analysis. Nutritional status was reassessed before each analyzed procedure using BMI calculated from height corrected by the Ylikoski formula and was linked to the postoperative outcome of the corresponding procedure. Generalized estimating equations (GEE) were used to evaluate factors associated with postoperative complications while accounting for within‐patient clustering. Results: A total of 14 procedures resulted in postoperative complications, yielding an overall complication rate of 16.3% (14/86), with 15 specific complication events recorded. After height‐adjusted BMI correction, 46 procedures were classified into the malnourished group and 40 into the normal nutrition group. The complication rate was significantly higher in the postadjusted malnourished group than in the normal nutrition group (23.9% vs. 7.5%, p = 0.042). Multivariable analysis using GEE revealed that undergoing ≥ 3 surgeries (OR = 4.614, 95% CI: 1.133–18.786, p = 0.033), and postadjusted malnutrition (OR = 3.701, 95% CI: 1.006–13.613, p = 0.049) were associated with increased risk of postoperative complications. However, after the Mancl–DeRouen small‐sample correction, the association between height‐adjusted malnutrition and complications was no longer statistically significant (OR = 4.21, 95% CI: 0.38–46.12, p = 0.239). Conclusions: Height‐adjusted malnutrition and repeated surgeries (≥ 3) were associated with increased postoperative complications after growing‐rod surgery in EOS patients. However, larger cohorts are needed to confirm these findings. The procedure‐specific application of height‐adjusted BMI provides an alternative approach to longitudinal nutritional assessment during repeated growing‐rod treatment. Timely intervention should be implemented for patients with poorer nutritional status.
- 6 November 2026
- Published by Wiley in Orthopaedic Surgery
Open AccessThe Influence of Height‐Adjusted Nutritional Status Assessment on Complications Following Growing‐Rod Surgery for Early‐Onset Scoliosis
Objectives: Accurate nutritional assessment in children with early‐onset scoliosis (EOS) is challenging because spinal deformity reduces measured standing height and may distort BMI‐for‐age classification. This study aimed to evaluate, using a longitudinal design, height‐adjusted nutritional status before each growing‐rod procedure throughout the treatment course and to investigate its association with postoperative complications in patients with EOS. Methods: A retrospective cohort study included 53 patients with EOS who underwent 86 growing‐rod procedures between January 2016 and January 2023, with each procedure serving as the unit of analysis. Nutritional status was reassessed before each analyzed procedure using BMI calculated from height corrected by the Ylikoski formula and was linked to the postoperative outcome of the corresponding procedure. Generalized estimating equations (GEE) were used to evaluate factors associated with postoperative complications while accounting for within‐patient clustering. Results: A total of 14 procedures resulted in postoperative complications, yielding an overall complication rate of 16.3% (14/86), with 15 specific complication events recorded. After height‐adjusted BMI correction, 46 procedures were classified into the malnourished group and 40 into the normal nutrition group. The complication rate was significantly higher in the postadjusted malnourished group than in the normal nutrition group (23.9% vs. 7.5%, p = 0.042). Multivariable analysis using GEE revealed that undergoing ≥ 3 surgeries (OR = 4.614, 95% CI: 1.133–18.786, p = 0.033), and postadjusted malnutrition (OR = 3.701, 95% CI: 1.006–13.613, p = 0.049) were associated with increased risk of postoperative complications. However, after the Mancl–DeRouen small‐sample correction, the association between height‐adjusted malnutrition and complications was no longer statistically significant (OR = 4.21, 95% CI: 0.38–46.12, p = 0.239). Conclusions: Height‐adjusted malnutrition and repeated surgeries (≥ 3) were associated with increased postoperative complications after growing‐rod surgery in EOS patients. However, larger cohorts are needed to confirm these findings. The procedure‐specific application of height‐adjusted BMI provides an alternative approach to longitudinal nutritional assessment during repeated growing‐rod treatment. Timely intervention should be implemented for patients with poorer nutritional status.
- Open Access
- 13 March 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 20 (2) , 401-402
Response to the letter to the editor: Complications and curve progression in EOS patients with extended distraction surgery intervals in growing rod surgery: a retrospective cohort study in China
- 13 March 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 20 (2) , 401-402
Open AccessResponse to the letter to the editor: Complications and curve progression in EOS patients with extended distraction surgery intervals in growing rod surgery: a retrospective cohort study in China
- Open Access
- 30 June 2025
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 19 (3) , 399-407
Complications and curve progression in EOS patients with extended distraction surgery intervals in growing rod surgery: a retrospective cohort study in China
Study Design: Retrospective case-control study.Purpose: This study aimed to explore the relationship between the rod-lengthening interval and the incidence of postoperative complications as well as the outcomes in patients with early-onset scoliosis (EOS) undergoing growing rod surgery.Overview of Literature: EOS is characterized by a spinal deformity that manifests before the age of 10 years. The growing rod technique allows for spinal curvature correction while preserving spinal growth through periodic lengthening surgeries typically performed every 6 months. However, we found that due to challenges, many patients undergo a 1-year or even longer interval between lengthening surgeries.Methods: We conducted a retrospective analysis of 59 patients with EOS who underwent growing rod surgery at our institution between August 2012 and June 2022. We collected radiographic parameters to compare the differences in outcomes and complications between patients who underwent lengthening surgeries at intervals of 12 months versus those with intervals of >12 months.Results: In this study, we found 29 complications in 59 patients. The complication rate was significantly lower in the group with lengthening intervals of 12 months compared with the group with intervals longer than 12 months (35.3% vs. 68%, p <0.05). In addition, patients in the group with intervals of 12 months showed less progression of the main curve, a lower maximum kyphosis angle, and greater increases in height in the fixed segments (d=7.53±3.69 cm, p <0.05). In contrast, patients with lengthening intervals longer than 12 months were more likely to experience sagittal plane imbalance (p <0.05).Conclusions: Lengthening intervals of greater than 12 months have a higher rate of complications and increase the risk of curve progression and spinal imbalance. Increasing the interval time just to minimize the number of surgeries before the final fusion is unwise.
- 30 June 2025
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 19 (3) , 399-407
Open AccessComplications and curve progression in EOS patients with extended distraction surgery intervals in growing rod surgery: a retrospective cohort study in China
Study Design: Retrospective case-control study.Purpose: This study aimed to explore the relationship between the rod-lengthening interval and the incidence of postoperative complications as well as the outcomes in patients with early-onset scoliosis (EOS) undergoing growing rod surgery.Overview of Literature: EOS is characterized by a spinal deformity that manifests before the age of 10 years. The growing rod technique allows for spinal curvature correction while preserving spinal growth through periodic lengthening surgeries typically performed every 6 months. However, we found that due to challenges, many patients undergo a 1-year or even longer interval between lengthening surgeries.Methods: We conducted a retrospective analysis of 59 patients with EOS who underwent growing rod surgery at our institution between August 2012 and June 2022. We collected radiographic parameters to compare the differences in outcomes and complications between patients who underwent lengthening surgeries at intervals of 12 months versus those with intervals of >12 months.Results: In this study, we found 29 complications in 59 patients. The complication rate was significantly lower in the group with lengthening intervals of 12 months compared with the group with intervals longer than 12 months (35.3% vs. 68%, p <0.05). In addition, patients in the group with intervals of 12 months showed less progression of the main curve, a lower maximum kyphosis angle, and greater increases in height in the fixed segments (d=7.53±3.69 cm, p <0.05). In contrast, patients with lengthening intervals longer than 12 months were more likely to experience sagittal plane imbalance (p <0.05).Conclusions: Lengthening intervals of greater than 12 months have a higher rate of complications and increase the risk of curve progression and spinal imbalance. Increasing the interval time just to minimize the number of surgeries before the final fusion is unwise.
- Open Access
- 1 June 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1) , 473-482
Efficacy of Halo Pelvic Traction Versus Halo Gravity Traction in Treating Severe Rigid Spinal Deformities: A Matched Retrospective Study
Study Design: Matched Retrospective Cohort Study. Objective: To compare efficacy and safety of Halo gravity traction vs Halo pelvic traction in severe rigid spinal deformity. Methods: We retrospectively reviewed 104 severe rigid spinal deformity patients treated with preoperative Halo traction and posterior correction surgery (2016.1-2022.12). Patients were matched 1:1 by main curve Cobb angle and age into HGT and HPT groups (33 each). Radiographic parameters were assessed before and after traction, preoperatively, and at final follow-up. Surgical planning for osteotomy and fusion segments used pre-traction imaging, compared with actual outcomes. Traction duration, surgical parameters, and complications were recorded. Results: HGT patients had 4.5 ± 1.5 months traction, improving main curve from 138.4° to 94.9° (23.5%) and kyphosis from 87.9° to 73.1° (22.6%), with postoperative values of 51.1° and 39.7°. HPT patients had 5.1 ± 1.1 months of traction, improving main curve from 143.2° to 69.6° (51.3%) and kyphosis from 117.7° to 56.8° (49.1%), with postoperative values of 56.1° and 34.5°. HPT showed better improvement ( P < 0.05). HPT achieved 50% deformity improvement after 3 months, vs 5 months for HGT. By 7 months, >60% of HPT vs P < 0.05) and fusion segments ( P = 0.02) more effectively. Complication rates were similar. Conclusions: Both HGT and HPT improve preoperative deformity, but HPT is more effective and better in reducing osteotomy grades and fusion segments.
- 1 June 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1) , 473-482
Open AccessEfficacy of Halo Pelvic Traction Versus Halo Gravity Traction in Treating Severe Rigid Spinal Deformities: A Matched Retrospective Study
Study Design: Matched Retrospective Cohort Study. Objective: To compare efficacy and safety of Halo gravity traction vs Halo pelvic traction in severe rigid spinal deformity. Methods: We retrospectively reviewed 104 severe rigid spinal deformity patients treated with preoperative Halo traction and posterior correction surgery (2016.1-2022.12). Patients were matched 1:1 by main curve Cobb angle and age into HGT and HPT groups (33 each). Radiographic parameters were assessed before and after traction, preoperatively, and at final follow-up. Surgical planning for osteotomy and fusion segments used pre-traction imaging, compared with actual outcomes. Traction duration, surgical parameters, and complications were recorded. Results: HGT patients had 4.5 ± 1.5 months traction, improving main curve from 138.4° to 94.9° (23.5%) and kyphosis from 87.9° to 73.1° (22.6%), with postoperative values of 51.1° and 39.7°. HPT patients had 5.1 ± 1.1 months of traction, improving main curve from 143.2° to 69.6° (51.3%) and kyphosis from 117.7° to 56.8° (49.1%), with postoperative values of 56.1° and 34.5°. HPT showed better improvement ( P < 0.05). HPT achieved 50% deformity improvement after 3 months, vs 5 months for HGT. By 7 months, >60% of HPT vs P < 0.05) and fusion segments ( P = 0.02) more effectively. Complication rates were similar. Conclusions: Both HGT and HPT improve preoperative deformity, but HPT is more effective and better in reducing osteotomy grades and fusion segments.
- Open Access
- 31 March 2023
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 20 (1) , 205-220
The Incidence, Changes and Treatments of Cervical Deformity After Infection and Inflammation
A healthy cervical spine with normal movement is the basis of many daily activities and is essential for maintaining a good quality of life. However, the alignment, fusion, and structure of the cervical spine can change for various reasons, leading to cervical deformity, mainly kyphosis. Approximately 5%‒20% of spinal infections in the cervical spine cause cervical deformity. The deformity can recover early; however, the disease's long-term existence or the continuous action of abnormal stress may lead to intervertebral fusion and abnormal osteophytes. Many gaps and controversies exist regarding infectious cervical deformities, including a lack of clear definitions and an acceptable classification system thereby requiring further research. Moreover, there is no consensus on the indications for postinfectious cervical deformity associated with Mycobacterium tuberculosis, Staphylococcus aureus, and Brucellosis. Therefore, we reviewed and discussed the incidence, clinical manifestations, changes, and treatment of infectious and inflammatory secondary cervical deformities from common to rare to provide a theoretical basis for clinical decision-making.
- 31 March 2023
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 20 (1) , 205-220
Open AccessThe Incidence, Changes and Treatments of Cervical Deformity After Infection and Inflammation
A healthy cervical spine with normal movement is the basis of many daily activities and is essential for maintaining a good quality of life. However, the alignment, fusion, and structure of the cervical spine can change for various reasons, leading to cervical deformity, mainly kyphosis. Approximately 5%‒20% of spinal infections in the cervical spine cause cervical deformity. The deformity can recover early; however, the disease's long-term existence or the continuous action of abnormal stress may lead to intervertebral fusion and abnormal osteophytes. Many gaps and controversies exist regarding infectious cervical deformities, including a lack of clear definitions and an acceptable classification system thereby requiring further research. Moreover, there is no consensus on the indications for postinfectious cervical deformity associated with Mycobacterium tuberculosis, Staphylococcus aureus, and Brucellosis. Therefore, we reviewed and discussed the incidence, clinical manifestations, changes, and treatment of infectious and inflammatory secondary cervical deformities from common to rare to provide a theoretical basis for clinical decision-making.
- 12 December 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (6) , 10137-10144
Polydatin suppresses the development of lung inflammation and fibrosis by inhibiting activation of the NACHT domain‐, leucine‐rich repeat‐, and pyd‐containing protein 3 inflammasome and the nuclear factor‐κB pathway after Mycoplasma pneumoniae infection
Mycoplasma pneumoniae (MP) can infect both the upper and lower respiratory tracts. Polydatin (PD), a traditional Chinese medicine, is known to have anti‐inflammation and antifibrosis properties. However, the protective effects of PD against MP pneumonia (MPP) remain unclear. So, the aim of this study was to describe the therapeutic effects and underlying mechanisms of PD against MPP. BALB/c mice were assigned to three groups: a normal control group, MP infection group, or PD‐treated MP infection group. BEAS‐2B cells transfected with or without NACHT domain‐, leucine‐rich repeat‐, and pyd‐containing protein 3 (NLRP3) were used to confirm the protective mechanisms of PD. Immunohistochemical analysis, Western blot analysis, enzyme‐linked immunosorbent assay, and flow cytometry were used in this study. The results showed that PD treatment suppressed MP‐induced lung injury in mice by suppressing the expression of inflammatory factors and inhibiting the development of pulmonary fibrosis. Meanwhile, PD treatment inhibited activation of the NLRP3 inflammasome and nuclear factor κB (NF‐κB) pathway. Overexpression of NLRP3 reversed the protective effect of PD against MP‐induced injury of BEAS‐2B cells. Taken together, these results indicate that PD treatment suppressed the inflammatory response and the development of pulmonary fibrosis by inhibiting the NLRP3 inflammasome and NF‐κB pathway after MP infection.
- 12 December 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (6) , 10137-10144
Polydatin suppresses the development of lung inflammation and fibrosis by inhibiting activation of the NACHT domain‐, leucine‐rich repeat‐, and pyd‐containing protein 3 inflammasome and the nuclear factor‐κB pathway after Mycoplasma pneumoniae infection
Mycoplasma pneumoniae (MP) can infect both the upper and lower respiratory tracts. Polydatin (PD), a traditional Chinese medicine, is known to have anti‐inflammation and antifibrosis properties. However, the protective effects of PD against MP pneumonia (MPP) remain unclear. So, the aim of this study was to describe the therapeutic effects and underlying mechanisms of PD against MPP. BALB/c mice were assigned to three groups: a normal control group, MP infection group, or PD‐treated MP infection group. BEAS‐2B cells transfected with or without NACHT domain‐, leucine‐rich repeat‐, and pyd‐containing protein 3 (NLRP3) were used to confirm the protective mechanisms of PD. Immunohistochemical analysis, Western blot analysis, enzyme‐linked immunosorbent assay, and flow cytometry were used in this study. The results showed that PD treatment suppressed MP‐induced lung injury in mice by suppressing the expression of inflammatory factors and inhibiting the development of pulmonary fibrosis. Meanwhile, PD treatment inhibited activation of the NLRP3 inflammasome and nuclear factor κB (NF‐κB) pathway. Overexpression of NLRP3 reversed the protective effect of PD against MP‐induced injury of BEAS‐2B cells. Taken together, these results indicate that PD treatment suppressed the inflammatory response and the development of pulmonary fibrosis by inhibiting the NLRP3 inflammasome and NF‐κB pathway after MP infection.
- Open Access
- 1 January 2010
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (1) , 170-176
In Vitro and In Vivo Efficacies of Teicoplanin-Loaded Calcium Sulfate for Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis
The i n vitro and in vivo therapeutic efficacies of teicoplanin-loaded calcium sulfate (TCS; 10% [wt] teicoplanin) were investigated in a rabbit model of chronic methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. The in vitro elution characteristics of teicoplanin from TCS pellets were realized by carrying out an evaluation of the release kinetics, recovery rate, and antibacterial activity of the released teicoplanin. Chronic osteomyelitis was induced by inoculating 10 7 CFU of a MRSA strain into the tibial cavity of rabbits. After 3 weeks, the animals were treated by debridement followed by implantation of TCS pellets in group 1, calcium sulfate (CS) pellets alone in group 2, and intravenous (i.v.) teicoplanin (6 mg/kg of body weight every 12 h for three doses and then every 24 h up to 4 weeks) in group 3. Animals in group 4 were left untreated. After 6 weeks, the efficacy of the osteomyelitis treatment was evaluated by hematological, radiological, microbiological, and histological examinations. In vitro elution studies showed sustained release of teicoplanin at a therapeutic level over a time period of 3 weeks. The released teicoplanin maintained its antibacterial activity. In vivo , the best therapeutic effect was observed in animals treated with TCS pellets, resulting in significantly lower radiological and histological scores, lower positive rates of MRSA culture and bacterial load, and excellent bone regeneration compared with those treated by CS alone or i.v. teicoplanin, without any local or systemic adverse effects. TCS pellets are an effective alternative to i.v. teicoplanin for the treatment of chronic MRSA osteomyelitis, particularly because teicoplanin is delivered locally while the TCS pellets simultaneously promote bone defect repair.
- 1 January 2010
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (1) , 170-176
Open AccessIn Vitro and In Vivo Efficacies of Teicoplanin-Loaded Calcium Sulfate for Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis
The i n vitro and in vivo therapeutic efficacies of teicoplanin-loaded calcium sulfate (TCS; 10% [wt] teicoplanin) were investigated in a rabbit model of chronic methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. The in vitro elution characteristics of teicoplanin from TCS pellets were realized by carrying out an evaluation of the release kinetics, recovery rate, and antibacterial activity of the released teicoplanin. Chronic osteomyelitis was induced by inoculating 10 7 CFU of a MRSA strain into the tibial cavity of rabbits. After 3 weeks, the animals were treated by debridement followed by implantation of TCS pellets in group 1, calcium sulfate (CS) pellets alone in group 2, and intravenous (i.v.) teicoplanin (6 mg/kg of body weight every 12 h for three doses and then every 24 h up to 4 weeks) in group 3. Animals in group 4 were left untreated. After 6 weeks, the efficacy of the osteomyelitis treatment was evaluated by hematological, radiological, microbiological, and histological examinations. In vitro elution studies showed sustained release of teicoplanin at a therapeutic level over a time period of 3 weeks. The released teicoplanin maintained its antibacterial activity. In vivo , the best therapeutic effect was observed in animals treated with TCS pellets, resulting in significantly lower radiological and histological scores, lower positive rates of MRSA culture and bacterial load, and excellent bone regeneration compared with those treated by CS alone or i.v. teicoplanin, without any local or systemic adverse effects. TCS pellets are an effective alternative to i.v. teicoplanin for the treatment of chronic MRSA osteomyelitis, particularly because teicoplanin is delivered locally while the TCS pellets simultaneously promote bone defect repair.